Cancer Institute A national cancer institute
designated cancer center

Matthew Bogyo

Publication Details

  • Lysine 188 substitutions convert the pattern of proteasome activation by REG gamma to that of REGs alpha and beta EMBO JOURNAL Li, J., Gao, X. L., Ortega, J. Q., Nazif, T., Joss, L., Bogyo, M., STEVEN, A. C., Rechsteiner, M. 2001; 20 (13): 3359-3369


    11S REGs (PA28s) are multimeric rings that bind proteasomes and stimulate peptide hydrolysis. Whereas REGalpha activates proteasomal hydrolysis of peptides with hydrophobic, acidic or basic residues in the P1 position, REGgamma only activates cleavage after basic residues. We have isolated REGgamma mutants capable of activating the hydrolysis of fluorogenic peptides diagnostic for all three active proteasome beta subunits. The most robust REGgamma specificity mutants involve substitution of Glu or Asp for Lys188. REGgamma(K188E/D) variants are virtually identical to REGalpha in proteasome activation but assemble into less stable heptamers/hexamers. Based on the REGalpha crystal structure, Lys188 of REGgamma faces the aqueous channel through the heptamer, raising the possibility that REG channels function as substrate-selective gates. However, covalent modification of proteasome chymotrypsin-like subunits by 125I-YL3-VS demonstrates that REGgamma(K188E)'s activation of all three proteasome active sites is not due to relaxed gating. We propose that decreased stability of REGgamma(K188E) heptamers allows them to change conformation upon proteasome binding, thus relieving inhibition of the CT and PGPH sites normally imposed by the wild-type REGgamma molecule.

    View details for Web of Science ID 000169803700009

    View details for PubMedID 11432824

Stanford Medicine Resources:

Footer Links: